The intelligence layer for
clinical research
Building Health Care Solutions Through Trusted Partnerships
Long-term partnerships with healthcare centres, seamlessly connecting their data through our federated AI network to optimise clinical data management and utilise RWD for impactful insights
Deeply curated data spanning structured records, unstructured notes, imaging, molecular data, and physiologic signals
40M+ Patient Lives
18B+
Radiology Images
Access images and linked reports across CT, MR, PET, ultrasound, X-ray, and additional imaging modalities.
2.7B+
Clinical Notes
Unlock unstructured clinical evidence from physician notes, reports, histories, and other narrative documentation.
38M+
Pathology Reports
Work with digital pathology and other image based evidence for biomarker discovery and model development.
100M+
Echo Videos
Analyze echocardiography videos to assess cardiac structure and function across patient records.
270K+
Genomic Reports
Access genomic data from patients with sequenced genes and recorded gene panels.
15M+
ECG Waveforms
Connect ECG waveforms with clinical context for deeper longitudinal analysis of cardiac health.
Federated access across leading health system partners
Longitudinal patient journeys with rich source level evidence
Privacy preserving de identification and harmonization
Federated access across leading health system partners
Longitudinal patient journeys with rich source level evidence
Privacy preserving de identification and harmonization
Therapeutic Areas
Discover comprehensive data dictionaries, curated by clinical specialists, detailing key variables for various disease areas.
Approximately 48% of Americans over 20 are affected by cardiovascular diseases. Our Real world evidence platform supports research that enhances clinical data analysis to improve patient outcomes.
Oncology
As cancer cases are projected to surpass 35 million by 2025, oncology research is paramount. Our data empowers researchers to expedite the discovery and development of effective cancer therapies.
Immunology
As the recent pandemic has shown, immunological breakthroughs can help save millions of lives. Our data and technology enable leading-edge immunology clinical trials leading to drug efficacy.
Rare Diseases
300 million people worldwide are affected by over 7000 known rare diseases, with 72% of them being genetic. Our novel molecular data helps to find genomic changes.
Neurology
Over 3 billion people worldwide suffer from neurological conditions. Our mission is to support the development of newer, more effective therapies.
Infectious Diseases
Around 1 billion individuals worldwide are affected by various infectious diseases. We aid scientists to combat these diseases by developing effective prevention and treatment strategies
Products & Services
AI-powered platform for clinical data analysis, patient cohorts, clinical journeys, and predictive models.
Design Patient Cohorts
Explore Patient Journey
Data Annotation for Model Development
AI Platform for Anatomical Computations
Advanced Data Science Workbench
Peer-Reviewed & Proven
See how nference’s data drives real world insights.
Oral Wegovy is associated with greater early weight loss than Foundayo in propensity matched adult GLP-1 users
In a small subset with 90-day follow-up weights, oral Wegovy was associated with greater early weight loss than Foundayo; comparative safety findings remain exploratory.
Prediagnostic Evolution of Polyendocrine Metabolic Ovarian Syndrome (PMOS): Pediatric Obesity, 10–15 Years of Elevated Weight, and Adiposity Rewiring
The study examined the metabolic history preceding the syndrome’s first recorded diagnosis.
Oral Wegovy Broadens Care Continuum Across First-Time GLP-Starters, High Cardiometabolic Burden GLP-Switchers, and Medicare-Age Patients
The study characterized care pathways before oral semaglutide initiation.
Venture creation powered by the nference platform
Harnessing industry-leading AI and translational science to decode the electrocardiogram as never before – as a deep predictive tool and biomarker of disease – empowering care providers to help patients early
Anumana website
Pramana is now part of Evident. Pramana is a health technology company that enables seamless digital adoption by pathology labs and medical centers.
Pramana website
Powering Quantum Leaps In Human Health
Hear from our Co-founder and Chief Scientific Officer Venky Soundararajan, as he discusses how AI is transforming precision medicine, from cancer diagnosis to heart disease care and beyond.
News and Updates
Whole-Body Spatial Intelligence Beyond Weight-loss: nference Advances Cardiometabolism Moat for Precision Peptide Medicines and Healthy Longevity
nference announced a series of publications from the Metabolic Agentic Intelligence Atlas initiative, or MAIA, a federated AI program that enables real-time synthesis of biomedical knowledge from the de-identified care patterns of over 30 million patients. The studies provide collectively, for the first-time, a high-resolution precision map of the impact of GLP-1, GIP, and other incretin therapies on the whole human body beyond weight-loss and glucose measurements that have been the primary endpoints of clinical studies thus far.
Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds
Eli Lilly's (LLY.N), opens new tab GLP-1 drug tirzepatide yields greater weight loss on average than Novo Nordisk's (NOVOb.CO), opens new tab semaglutide, but at a greater expense to muscles and connective tissues, according to a study published this week ahead of peer review.
nference and Rush University System for Health Launch Long-Term Partnership to Advance AI-Enabled Clinical Research and Patient Care
Partnership will create a real-time, secure, Rush-hosted platform that makes de-identified, multimodal clinical data research-ready to accelerate discovery and improve patient care.
© 2026 nference, Inc. All rights reserved.
Your Privacy Choices